Proteomic Biomarker Tests in Blood Samples from Children with Autism Spectrum Disorder (ASD)

RecruitingOBSERVATIONAL
Enrollment

900

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
Autistic Disorder
Interventions
DIAGNOSTIC_TEST

Blood draw

A blood sample (5 mL) will be collected.

DIAGNOSTIC_TEST

Stool Sample Collection

Subjects will be provided a dry, plastic, screw-top specimen container and will be asked to collect a stool sample at home.

DIAGNOSTIC_TEST

Urine Sample Collection

Subjects will be provided a dry, plastic, screw-top specimen container and will be asked to collect a urine sample at home.

Trial Locations (1)

91031

RECRUITING

Shaare Zedek Medical Center, Jerusalem

All Listed Sponsors
collaborator

Shaare Zedek Medical Center

OTHER

lead

Benjamin Gesundheit

INDUSTRY

NCT02168868 - Proteomic Biomarker Tests in Blood Samples from Children with Autism Spectrum Disorder (ASD) | Biotech Hunter | Biotech Hunter